請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84357完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 董鈺琪(Yu-Chi Tung) | |
| dc.contributor.author | Shih-An Liu | en |
| dc.contributor.author | 劉時安 | zh_TW |
| dc.date.accessioned | 2023-03-19T22:09:20Z | - |
| dc.date.copyright | 2022-07-02 | |
| dc.date.issued | 2022 | |
| dc.date.submitted | 2022-05-12 | |
| dc.identifier.citation | 一、中文部分 衛生福利部國民健康署108年癌症登記報告,發布日:民國111年01月13日,網址: https://www.hpa.gov.tw/Pages/ashx/File.ashx?FilePath=~/File/Attach/14913/File_17794.pdf引用2022/01/29 衛生福利部中央健康保險署,109年全民健保惡性腫瘤醫療支出「排名前十大癌別之醫療費用支出統計表」,更新日期:民國110年9月13日,網址:https://www.nhi.gov.tw/DL.aspx?sitessn=292&u=LzAwMS9VcGxvYWQvMjkyL3JlbGZpbGUvMC8xNDY1MjYvMTA55bm05ZCE6aGe55mM55eH55eF5Lq66Jel6LK75Y%2BK6Yar55mC6LK755So57Wx6KiIKOaJgOacieaDoeaAp%2BiFq%2BeYpClf5o%2BQ5L6b5pys572y5YWo55CD6LOH6KiK57ayLnBkZg%3D%3D&n=MTA55bm05ZCE6aGe55mM55eH55eF5Lq66Jel6LK75Y%2BK6Yar55mC6LK755So57Wx6KiIKOaJgOacieaDoeaAp%2BiFq%2BeYpClf5o%2BQ5L6b5pys572y5YWo55CD6LOH6KiK57ayLnBkZg%3D%3D&ico%20=.pdf 引用2022/01/29 衛生福利部中央健康保險署:「全民健康保險醫療服務給付項目及支付標準」,衛生福利部中央健康保險署網站,更新日期:民國110年11月22日,網址: https://www.nhi.gov.tw/Content_List.aspx?n=58ED9C8D8417D00B&topn=5FE8C9FEAE863B46 引用2022/01/29 口腔癌臨床診療指引/TCOG臺灣癌症臨床研究合作組織口腔癌工作群編撰小組著,第一版,國家衛生研究院,民國110年12月 二、英文部分 Alicandri-Ciufelli M, Bonali M, Piccinini A, Marra L, Ghidini A, Cunsolo EM, Maiorana A, Presutti L, Conte PF. Surgical margins in head and neck squamous cell carcinoma: what is 'close'? Eur Arch Otorhinolaryngol. 2013;270:2603-9. doi: 10.1007/s00405-012-2317-8. Al-Shwaiheen FA, Wang SJ, Uzelac A, Yom SS, Ryan WR. (2015). The advantages and drawbacks of routine magnetic resonance imaging for long-term post-treatment locoregional surveillance of oral cavity squamous cell carcinoma. Am J Otolaryngol 2015;36:415-23. doi: 10.1016/j.amjoto.2015.01.024. Amin MB, Edge SB, Greene FL, et al: AJCC Cancer Staging Manual, Eighth Edition. American Joint Committee on Cancer, Springer, 2018;3-94. Anastasio, KM, Bernard SP, Briggs RE, et al. ICD-10-CM/PCS Coding: Theory and Practice, 2019/2020 Edition E-Book, Elsevier, 2020;217-59. Baxi SS, Kale M, Keyhani S, et al. Overuse of Health Care Services in the Management of Cancer: A Systematic Review. Med Care 2017;55:723-33. doi: 10.1097/MLR.0000000000000734. Benamore R, Shepherd FA, Leighl N, et al. Does intensive follow-up alter outcome in patients with advanced lung cancer? J Thorac Oncol 2007;2:273-81. doi: 10.1097/01.JTO.0000263708.08332.76. Borsetto D, Sethi M, Polesel J, et al. The risk of recurrence in surgically treated head and neck squamous cell carcinomas: a conditional probability approach. Acta Oncol 2021;60:942-7. doi: 10.1080/0284186X.2021.1925343. Buck CJ. ICD-9-CM. W.B. Saunders Company, 2001;1308p. Chan DL, Cheung M, Earle CC, et al. Are We Choosing Surveillance Imaging in Gastric and Pancreatic Cancers Wisely? A Population-Based Study. J Gastrointest Cancer 2020;51:189-95. doi: 10.1007/s12029-019-00235-8. Chatzistefanou I, Lubek J, Markou K, Ord RA. The role of perineural invasion in treatment decisions for oral cancer patients: A review of the literature. J Craniomaxillofac Surg. 2017;45:821-5. doi: 10.1016/j.jcms.2017.02.022. Dabestani S, Beisland C, Stewart GD, et al. Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR). Eur Urol 2019;75:261-4. doi: 10.1016/j.eururo.2018.10.007. Deal AM, Patel MR, Thorp BD, Cannon TY, Shores CG, Zanation AM. Liver function tests: inadequate screening modality for detection of liver metastasis in head and neck carcinoma. Otolaryngol Head Neck Surg 2012;146:88-91. doi: 10.1177/0194599811425147. de Visscher AV & Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg 1994;120:934-9. doi: 10.1001/archotol.1994.01880330022005. El-Galaly TC, Jakobsen LH, Hutchings M, et al. Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study. J Clin Oncol 2015;33:3993-8. doi: 10.1200/JCO.2015.62.0229. Giglio V, Schneider P, Madden K, et al. Published randomized controlled trials of surveillance in cancer patients - a systematic review. Oncol Rev 2021;15:522. doi: 10.4081/oncol.2021.522. Heineman TE, Kuan EC, St John MA. When should surveillance imaging be performed after treatment for head and neck cancer? Laryngoscope 2017;127:533-4. doi: 10.1002/lary.26268. Hodgson DC, Grunfeld E, Gunraj N, Del Giudice L. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects. Cancer 2010;116:3417-25. doi: 10.1002/cncr.25053. Høeg BL, Bidstrup PE, Karlsen RV, et al. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev 2019;2019:CD012425. doi: 10.1002/14651858.CD012425.pub2. Hyder O, Dodson RM, Mayo SC, et al. Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases. Surgery 2013;154:256-65. doi: 10.1016/j.surg.2013.04.021. Imbimbo M, Alfieri S, Botta L, et al. Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up. Otolaryngol Head Neck Surg 2019;161:635-42. doi: 10.1177/0194599819860808. Jakobsen LH, Hutchings M, de Nully Brown P, et al. No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study. Br J Haematol 2016;173:236-44. doi: 10.1111/bjh.13943. Korenstein D, Falk R, Howell EA, Bishop T, Keyhani S. Overuse of health care services in the United States: an understudied problem. Arch Intern Med 2012;172:171-8. doi: 10.1001/archinternmed.2011.772. PMID: 22271125. Lee DS, Ramirez RJ, Lee JJ, Valenzuela CV, Zevallos JP, Mazul AL, Puram SV, Doering MM, Pipkorn P, Jackson RS. Survival of Young Versus Old Patients With Oral Cavity Squamous Cell Carcinoma: A Meta-Analysis. Laryngoscope. 2021;131:1310-9. doi: 10.1002/lary.29260. Liberati A. The GIVIO trial on the impact of follow-up care on survival and quality of life in breast cancer patients. Interdisciplinary Group for Cancer Care Evaluation. Ann Oncol 1995;6 Suppl 2:41-6. doi: 10.1093/annonc/6.suppl_2.s41. Lin WJ, Jiang RS, Wu SH, Chen FJ, Liu SA. Smoking, alcohol, and betel quid and oral cancer: a prospective cohort study. J Oncol 2011;2011:525976. doi: 10.1155/2011/525976. Liu SA, Wang CC, Jiang RS, Wang WY, Lin JC. Genetic analysis of surgical margins in oral cavity cancer. Br J Surg 2018;105:e142-e149. doi: 10.1002/bjs.10693. Mascitti M, Togni L, Caponio VCA, Zhurakivska K, Bizzoca ME, Contaldo M, Serpico R, Lo Muzio L, Santarelli A. Lymphovascular invasion as a prognostic tool for oral squamous cell carcinoma: a comprehensive review. Int J Oral Maxillofac Surg. 2022;51:1-9. doi: 10.1016/j.ijom.2021.03.007. Miles RC, Lee CI, Sun Q, et al. Patterns of Surveillance Advanced Imaging and Serum Tumor Biomarker Testing Following Launch of the Choosing Wisely Initiative. J Natl Compr Canc Netw 2019;17:813-20. doi: 10.6004/jnccn.2018.7281. Moses MW, Pedroza P, Baral R, et al. Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016. Lancet Public Health 2019;4:e49-e73. doi: 10.1016/S2468-2667(18)30213-5. Mukdad L, Heineman TE, Alonso J, Badran KW, Kuan EC, St John MA. Oral tongue squamous cell carcinoma survival as stratified by age and sex: A surveillance, epidemiology, and end results analysis. Laryngoscope. 2019;129:2076-81. doi: 10.1002/lary.27720. Papagrigoriadis S. Follow-up of patients with colorectal cancer: the evidence is in favour but we are still in need of a protocol. Int J Surg 2007;5:120-8. doi: 10.1016/j.ijsu.2006.04.004. Park CH, Park JC, Chung H, et al. Impact of the Surveillance Interval on the Survival of Patients Who Undergo Curative Surgery for Gastric Cancer. Ann Surg Oncol 2016;23:539-45. doi: 10.1245/s10434-015-4866-8. PerryUndem Research/Communication. Conducted for The ABIM Foundation. Unnecessary Tests and Procedures In the Health Care System: What Physicians Say About The Problem, the Causes, and the Solutions – Results from a National Survey of Physicians. May 1, 2014 Risendal BC, Sedjo RL, Giuliano AR, et al. Surveillance and beliefs about follow-up care among long-term breast cancer survivors: a comparison of primary care and oncology providers. J Cancer Surviv 2016;10:96-102. doi: 10.1007/s11764-015-0454-y. Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 1994;271:1593-7. doi: 10.1001/jama.271.20.1593. Schnipper LE, Lyman GH, Blayney DW, et al. American Society of Clinical Oncology 2013 top five list in oncology. J Clin Oncol 2013;31:4362-70. doi: 10.1200/JCO.2013.53.3943. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998;114:7-14. doi: 10.1016/s0016-5085(98)70626-2. Simcock R & Simo R. Follow-up and Survivorship in Head and Neck Cancer Clin Oncol (R Coll Radiol) 2016;28:451-8. doi: 10.1016/j.clon.2016.03.004. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49. doi: 10.3322/caac.21660. Szturz P, Van Laer C, Simon C, Van Gestel D, Bourhis J, Vermorken JB. Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity. Front Oncol 2020;10:688. doi: 10.3389/fonc.2020.00688. Tagliabue M, Belloni P, De Berardinis R, Gandini S, Chu F, Zorzi S, Fumagalli C, Santoro L, Chiocca S, Ansarin M. A systematic review and meta-analysis of the prognostic role of age in oral tongue cancer. Cancer Med. 2021;10:2566-78. doi: 10.1002/cam4.3795. The National Comprehensive Cancer Network. NCCN guidelines for treatment of cancer by site, Head and Neck Cancers, 2021, Available at: https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf Accessed December 12, 2021 Tsai WC, Kung PT, Wang ST, Hunag KW, Liu SA. Beneficial impact of multi-disciplinary team management on the survival in different stages of oral cavity cancer patients: results of a nationwide cohort study in Taiwan. Oral Oncol 2015;51:105-11. doi: 10.1016/j.oraloncology.2014.11.006. Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer Treat Rev 2020;86:102019. doi: 10.1016/j.ctrv.2020.102019. Yamazaki H, Inoue T, Yoshida K, et al. Influence of age on the results of brachytherapy for early tongue cancer. Int J Radiat Oncol Biol Phys 2001;49:931-6. doi: 10.1016/s0360-3016(00)01454-1. Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest 1999;115:1494-9. doi: 10.1378/chest.115.6.1494. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84357 | - |
| dc.description.abstract | 研究背景與目的:根據臺灣癌登統計,以男性而言,口腔癌之發生率及死亡率均排名第三,為現階段臺灣最常見之頭頸癌。目前對於口腔癌病人治療後之追蹤計劃沒有一定的標準且仍欠缺共識,雖然大部份針對頭頸癌治療後追蹤計劃之研究指出影像學檢查及門診追蹤頻次與頭頸癌病人預後沒有統計學上之相關,唯大部份均不是專門針對口腔癌之研究。近來明智就醫之議題愈來愈受到重視,旨在促進病人與臨床醫師間的對話,避免不必要的醫學檢查、治療和程序。所以本研究之目的在於探討口腔癌病人,在接受完整治療後,不同影像學檢查頻率及門診次數對於預後之影響。 研究方法:本研究採回溯性之病歷回顧,利用臺中榮民總醫院之臨床資料庫之口腔癌病人,探討追蹤期間、電腦斷層/磁振造數次數、腹部超音波次數、骨骼掃瞄次數等變項對於預後之影響。分析方法採描述性統計及推論性統計呈現,存活分析以Kaplan-Meier法為之,不同組別之比較以對數-等級檢定 (log-rank test) 分析,影響存活的因素 (單變項及多變項分析) 以Cox比例風險模式(Cox proportional hazards model) 為之。 研究結果:總共有741位人納入最終分析,平均年齡為54.8歲,男性佔大多數 (655位,88.4%),最常見之原發部位為舌癌 (338位,45.6%),早期及晚期病人分別為391位(52.8%) 及350位 (47.2%),在追蹤期間有233位 (31.4%) 出現局部或區域性復發,166位 (22.4%) 在追蹤期間因口腔癌因素死亡,平均追蹤期間為47.9個月。追蹤期間每人平均接受電腦斷層/磁振造影為 5.0次,肝臟超音波為 2.9次,骨骼掃瞄為 2.3次,正子攝影為 1.6次,門診次數平均為42.3次。在多變項分析當中,整體而言,電腦斷層/磁振造影頻次、肝臟超音波頻次、及骨骼掃瞄頻次與口腔癌病人之疾病別死亡沒有統計學上之相關,但正子攝影與門診頻次與口腔癌病人之預後呈負相關。如將口腔癌病人根據期別及年齡分為兩組,我們發現在第三四期的口腔病人,較多的電腦斷層/磁振造影檢查 (>=1.3 次/年) 有較低之死亡風險 (死亡風險:0.52,95%信賴區間:0.34-0.81),而在大於等於54歲的口腔癌病人族群,較多之電腦斷層/磁振造影 (>=1.3 次/年) (死亡風險:0.51,95%信賴區間:0.29-0.90) 及肝臟超音波 (>=0.66 次/年) (死亡風險:0.56,95%信賴區間:0.32-0.99),都能減少口腔癌病人之死亡風險。 結論:口腔癌病人治療後的追蹤計劃應朝精準化之方向前進,針對早期及年輕 (小於54歲) 的口腔癌病人治療後,可依病人之症狀及醫師臨床檢查的結果來安排影像學檢查,但在晚期或年長 (大於等於54歲) 的口腔癌病人治療後,建議至少每年定期安排影像學之檢查,以期能早期發現復發,及早介入來提昇存活率。未來可運用多機構之資料 (如:健保資料庫) 來進一步探入分析。另也可以設計前瞻性之隨機分派研究,與其他機構進行多中心之臨床實驗來釐清影像學檢查與口腔癌病人預後的相關性。 | zh_TW |
| dc.description.abstract | Background & Purpose: According to the data from the Taiwan Cancer Registry, the incidence and mortality rate of oral cavity cancer patients all ranks 3rd among all cancers in male population. In addition, oral cavity cancer is the most prevalent head and neck cancer nowadays in Taiwan. There is no standard or consensus about the follow-up protocol after comprehensive treatment of oral cavity cancer patients. Although most studies about follow-up protocol after treatment of head and neck cancer patients indicated that there is no association between frequency of image studies and prognosis, few studies focused solely on oral cavity cancer patients. Choosing wisely is a current trend and its goal is to promote patient-physician conversations about unnecessary medical tests and procedures. The aim of this study was to investigate the relationship between the prognosis of oral cavity cancer patients and the frequency of image studies as well as the frequency of clinic visits. Methods: This is a retrospective study which was approved by the Institutional Review Board of Taichung Veterans Hospital (TCVGH). We used clinical database of TCVGH to explore oral cavity patients who were treated in TCVGH. We collected demographic data, follow-up duration, frequency of Computerized Tomography (CT)/Magnetic Resonance Imaging (MRI), abdominal sonogram, whole body bone scan, and clinic visits of oral cavity cancer patients after comprehensive treatment. Then we analyzed the association between abovementioned variables and prognosis of oral cavity cancer patients. Demographic data were presented by descriptive statistics and comparison between subgroups was analyzed with inferential statistics. Survival analysis was done by Kaplan-Meier method and comparison between different subgroups was analyzed by log-rank test. The variables related to prognosis of oral cavity cancer patients were examined by Cox proportional hazards model. Results: There were totally 741 oral cavity cancer patients enrolled into final analyses. The average age was 54.8 years and male accounted for most of the patients (n=655, 88.4%). In addition, the most common primary site was tongue (n=338, 45.6%). Patients with early stage disease and late stage disease were 391 (52.8%) and 350 (47.2%), respectively. Two hundred and thirty-three patients (31.4%) developed loco-regional recurrence while 166 patients (22.4%) died because of oral cavity cancer during follow-up period. Besides, the average follow-up period was 47.9 months. During follow-up period, the average numbers of examination per person for CT/MRI, liver sonogram, whole body bone scan, and Positron Emission Tomography (PET) were 5.0, 2.9, 2.3, and 1.6, respectively. The average clinic visits was 42.3 visits. In multivariate analysis, there were no significant statistic difference between prognosis of oral cavity cancer patients and image studies except PET scan. There was a negative correlation between prognosis of oral cavity cancer patients and frequency of PET scan after treatment. Also, more clinic visits was correlated with a poor prognosis of oral cavity cancer patients. We then divided all patients into subgroups based on tumor stage and age. We found more CT/MRI (>=1.3 times/year) was associated with a better prognosis in late stage oral cavity cancer patients (Odds ratio [OR] for mortality: 0.52,95% confidence interval [CI]: 0.34-0.81). In elder patients, disease-specific mortality rates were lower in patients receiving more CT/MRI (>=1.3 times/year) (OR: 0.51, 95% CI: 0.29-0.90) as well as more liver sonogram (>=0.66 times/year) (OR: 0.56, 95% CI: 0.32-0.99). Conclusion: Post-treatment surveillance of oral cavity cancer patients should be more precisely. Based on our study, we do not recommend routine image study in asymptomatic early and younger oral cavity cancer patients after comprehensive treatment. However, annually image study is recommended in elder or late stage oral cavity cancer patients in order to detect loco-regional recurrence in advance. Further large-scale study is warrant to clarify the relationship between prognosis of oral cavity cancer patients and post-treatment surveillance image studies. | en |
| dc.description.provenance | Made available in DSpace on 2023-03-19T22:09:20Z (GMT). No. of bitstreams: 1 U0001-1005202219032600.pdf: 3702855 bytes, checksum: c8d3202f569cb7e54410f3d79728c46a (MD5) Previous issue date: 2022 | en |
| dc.description.tableofcontents | 口試委員會審定書 I 致謝 II 中文摘要 III 英文摘要 V 目錄 VII 表目錄 IX 圖目錄 X 第一章 緒論 1 第一節 研究背景與動機 1 第二節 研究目的 5 第三節 研究重要性 5 第二章 文獻探討 6 第一節 口腔癌之介紹 6 第二節 明智就醫 (CHOOSING WISELY) 11 第三節 癌症治療後追蹤與預後之研究 13 第四節 頭頸癌治療後追蹤檢查與預後之研究與問題 15 第五節 綜合評論 16 第三章 研究方法 17 第一節 研究設計與架構 17 第二節 研究假說 18 第三節 研究對象 18 第四節 資料來源與資料處理流程 19 第五節 研究變項操作型定義 20 第六節 統計分析方法 21 第四章 研究結果 22 第一節 描述性統計 22 第二節 雙變項分析 23 第三節 多變項分析 53 第五章 討論 61 第一節 研究方法 61 第二節 研究結果 62 第三節 研究限制 65 第六章 結論與建議 67 第一節 結論 67 第二節 建議 67 參考文獻 69 | |
| dc.language.iso | zh-TW | |
| dc.subject | 明智就醫 | zh_TW |
| dc.subject | 影像學檢查 | zh_TW |
| dc.subject | 治療後追蹤 | zh_TW |
| dc.subject | 門診次數 | zh_TW |
| dc.subject | 口腔癌 | zh_TW |
| dc.subject | Clinic visit | en |
| dc.subject | Oral cavity cancer | en |
| dc.subject | Post-treatment surveillance | en |
| dc.subject | Choosing wisely | en |
| dc.subject | Image study | en |
| dc.title | 明智就醫: 口腔癌患者治療後追蹤計劃與預後之相關性-以中部某醫學中心為例 | zh_TW |
| dc.title | Choosing Wisely: The association between post-treatment surveillance and prognosis of oral cavity cancer patients - Result from a medical center in central Taiwan | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 110-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.author-orcid | 0000-0002-1213-9080 | |
| dc.contributor.oralexamcommittee | 王拔群(Pa-Chun Wang),鍾國彪(Kuo-Piao Chung) | |
| dc.subject.keyword | 口腔癌,治療後追蹤,明智就醫,影像學檢查,門診次數, | zh_TW |
| dc.subject.keyword | Oral cavity cancer,Post-treatment surveillance,Choosing wisely,Image study,Clinic visit, | en |
| dc.relation.page | 77 | |
| dc.identifier.doi | 10.6342/NTU202200759 | |
| dc.rights.note | 同意授權(限校園內公開) | |
| dc.date.accepted | 2022-05-12 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 健康政策與管理研究所 | zh_TW |
| dc.date.embargo-lift | 2022-07-02 | - |
| 顯示於系所單位: | 健康政策與管理研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| U0001-1005202219032600.pdf 授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務) | 3.62 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
